Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (International Journal of Hematology, (2017), 105, 3, (309-317), 10.1007/s12185-016-2130-z)

Norio Komatsu, Keita Kirito, Kazuya Shimoda, Takayuki Ishikawa, Kohshi Ohishi, Kazuma Ohyashiki, Naoto Takahashi, Hikaru Okada, Taro Amagasaki, Toshio Yonezu, Koichi Akashi

Research output: Contribution to journal › Comment/debate

Abstract

The author would like to correct the error in the publication of the original article. The corrected detail is given below for your reading: The first sentence in the “Results” section under the heading“Patients” should read as“A total of 51 patients were enrolled in this study from April 2014 to September 2014.”

Original languageEnglish
Number of pages1
JournalInternational journal of hematology
Volume105
Issue number3
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Primary Myelofibrosis
Hematology
Publications
Reading
Safety
INCB018424

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Erratum to : Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (International Journal of Hematology, (2017), 105, 3, (309-317), 10.1007/s12185-016-2130-z). / Komatsu, Norio; Kirito, Keita; Shimoda, Kazuya; Ishikawa, Takayuki; Ohishi, Kohshi; Ohyashiki, Kazuma; Takahashi, Naoto; Okada, Hikaru; Amagasaki, Taro; Yonezu, Toshio; Akashi, Koichi.

In: International journal of hematology, Vol. 105, No. 3, 01.03.2017.

Research output: Contribution to journal › Comment/debate

Komatsu, N, Kirito, K, Shimoda, K, Ishikawa, T, Ohishi, K, Ohyashiki, K, Takahashi, N, Okada, H, Amagasaki, T, Yonezu, T & Akashi, K 2017, 'Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (International Journal of Hematology, (2017), 105, 3, (309-317), 10.1007/s12185-016-2130-z)', International journal of hematology, vol. 105, no. 3. https://doi.org/10.1007/s12185-017-2196-2
Komatsu N, Kirito K, Shimoda K, Ishikawa T, Ohishi K, Ohyashiki K et al. Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (International Journal of Hematology, (2017), 105, 3, (309-317), 10.1007/s12185-016-2130-z). International journal of hematology. 2017 Mar 1;105(3). https://doi.org/10.1007/s12185-017-2196-2
Komatsu, Norio ; Kirito, Keita ; Shimoda, Kazuya ; Ishikawa, Takayuki ; Ohishi, Kohshi ; Ohyashiki, Kazuma ; Takahashi, Naoto ; Okada, Hikaru ; Amagasaki, Taro ; Yonezu, Toshio ; Akashi, Koichi. / Erratum to : Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (International Journal of Hematology, (2017), 105, 3, (309-317), 10.1007/s12185-016-2130-z). In: International journal of hematology. 2017 ; Vol. 105, No. 3.
@article{79890e875f6747a9b230ce7cf34b9ccd,
title = "Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (International Journal of Hematology, (2017), 105, 3, (309-317), 10.1007/s12185-016-2130-z)",
abstract = "The author would like to correct the error in the publication of the original article. The corrected detail is given below for your reading: The first sentence in the “Results” section under the heading“Patients” should read as“A total of 51 patients were enrolled in this study from April 2014 to September 2014.”",
author = "Norio Komatsu and Keita Kirito and Kazuya Shimoda and Takayuki Ishikawa and Kohshi Ohishi and Kazuma Ohyashiki and Naoto Takahashi and Hikaru Okada and Taro Amagasaki and Toshio Yonezu and Koichi Akashi",
year = "2017",
month = "3",
day = "1",
doi = "10.1007/s12185-017-2196-2",
language = "English",
volume = "105",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Erratum to

T2 - Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (International Journal of Hematology, (2017), 105, 3, (309-317), 10.1007/s12185-016-2130-z)

AU - Komatsu, Norio

AU - Kirito, Keita

AU - Shimoda, Kazuya

AU - Ishikawa, Takayuki

AU - Ohishi, Kohshi

AU - Ohyashiki, Kazuma

AU - Takahashi, Naoto

AU - Okada, Hikaru

AU - Amagasaki, Taro

AU - Yonezu, Toshio

AU - Akashi, Koichi

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The author would like to correct the error in the publication of the original article. The corrected detail is given below for your reading: The first sentence in the “Results” section under the heading“Patients” should read as“A total of 51 patients were enrolled in this study from April 2014 to September 2014.”

AB - The author would like to correct the error in the publication of the original article. The corrected detail is given below for your reading: The first sentence in the “Results” section under the heading“Patients” should read as“A total of 51 patients were enrolled in this study from April 2014 to September 2014.”

UR - http://www.scopus.com/inward/record.url?scp=85011827244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011827244&partnerID=8YFLogxK

U2 - 10.1007/s12185-017-2196-2

DO - 10.1007/s12185-017-2196-2

M3 - Comment/debate

C2 - 28176224

AN - SCOPUS:85011827244

VL - 105

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -

Access to Document